PuSH - Publikationsserver des Helmholtz Zentrums München

Hoeper, M.M.* ; Pausch, C.* ; Olsson, K.M.* ; Huscher, D.* ; Pittrow, D.* ; Grünig, E.* ; Staehler, G.* ; Vizza, C.D.* ; Gall, H.* ; Distler, O.* ; Opitz, C.* ; Gibbs, J.S.R.* ; Delcroix, M.* ; Ghofrani, H.A.* ; Park, D.H.* ; Ewert, R.* ; Kaemmerer, H.* ; Kabitz, H.J.* ; Skowasch, D.* ; Behr, J. ; Milger, K.* ; Halank, M.* ; Wilkens, H.* ; Seyfarth, H.J.* ; Held, M.* ; Dumitrescu, D.* ; Tsangaris, I.* ; Vonk-Noordegraaf, A.* ; Ulrich, S.* ; Klose, H.* ; Claussen, M.* ; Lange, T.J.* ; Rosenkranz, S.*

COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension.

Eur. Respir. J. 60:2102311 (2021)
Verlagsversion Postprint Forschungsdaten DOI PMC
Open Access Gold (Paid Option)
Creative Commons Lizenzvertrag
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary arterial hypertension (PAH). The current European guidelines propose a 3-strata model to categorise risk as low, intermediate, or high, based on the expected 1-year mortality. However, with this model, most patients are categorised as intermediate risk. We investigated a modified approach based on 4 risk categories with intermediate risk subdivided into intermediate-low and intermediate-high risk. METHODS: We analysed data from COMPERA, a European pulmonary hypertension registry, and calculated risk at diagnosis and first follow-up based on functional class (FC), 6 min walking distance (6 MWD) and serum levels of brain natriuretic peptide (BNP) or N-terminal fragment of pro-BNP (NT-proBNP), using refined cut-off values. Survival was assessed with Kaplan-Meier analyses, log-rank testing, and Cox proportional hazards models. RESULTS: Data from 1,655 patients with PAH were analysed. Using the 3-strata model, most patients were classified as intermediate risk (76.0% at baseline and 63.9% at first follow-up). The refined 4-strata risk model yielded a more nuanced separation and predicted long-term survival, especially at follow-up assessment. Changes in risk from baseline to follow-up were observed in 31.1% of the patients with the 3-strata model and in 49.2% with the 4-strata model. These changes, including those between the intermediate-low and intermediate-high strata, were associated with changes in long-term mortality risk. CONCLUSIONS: Modified risk stratification using a 4-strata model based on refined cut-off levels for FC, 6MWD and BNP/NT-proBNP was more sensitive to prognostically relevant changes in risk than the original 3-strata model.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
ISSN (print) / ISBN 0903-1936
e-ISSN 1399-3003
Zeitschrift European Respiratory Journal
Quellenangaben Band: 60, Heft: 1, Seiten: , Artikelnummer: 2102311 Supplement: ,
Verlag European Respiratory Society
Verlagsort Sheffield
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Lung Health and Immunity (LHI)